Clinical Trial Update: Contrast Enhanced Ultrasound Evaluation of Brain Perfusion in Neonatal Post-Hemorrhagic Hydrocephalus [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating contrast-enhanced ultrasound for brain perfusion in neonatal post-hemorrhagic hydrocephalus has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neonatal Post-hemorrhagic Hydrocephalus

Snippet

Sponsor: Johns Hopkins University | Conditions: Neonatal Post-Hemorrhagic Hydrocephalus | Phase 4 | Status: WITHDRAWN